TNF and rheumatoid arthritis: Additionally, Koopman et al. developed the first clinical trial using VNS to treat RA, in which a set of 17 RA patients submitted to an 84 day open-label trial revealed significantly decreased TNF production and significantly improved clinical symptoms (Koopman et al. 2016).